Wang G - Search Results

1

Capacity building for assessing new technologies: approaches to examining personalized medicine in practice.

Van Bebber SL, Trosman JR, Liang SY, Wang G, Marshall DA, Knight S, Phillips KA. Van Bebber SL, et al. Among authors: wang g. Per Med. 2010 Jul;7(4):427-439. doi: 10.2217/pme.10.36. Per Med. 2010. PMID: 21857867 Free PMC article.

2

Differences in US healthcare coverage policies in BRCA testing and potential implications.

Beattie MS, Wang G, Phillips KA. Beattie MS, et al. Among authors: wang g. Per Med. 2012 Jan;9(1):5-8. doi: 10.2217/pme.11.85. Per Med. 2012. PMID: 29783285 No abstract available.

3

Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer.

Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS. Liang SY, et al. Among authors: wang g. Med Care. 2011 Jun;49(6):e1-8. doi: 10.1097/MLR.0b013e318207e87e. Med Care. 2011. PMID: 21422962 Free PMC article.

4

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.

Wang G, Beattie MS, Ponce NA, Phillips KA. Wang G, et al. Genet Med. 2011 Dec;13(12):1045-50. doi: 10.1097/GIM.0b013e31822a8113. Genet Med. 2011. PMID: 21844812 Free PMC article.

5

Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome.

Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Wang G, et al. J Oncol Pract. 2012 May;8(3 Suppl):e24s-30s. doi: 10.1200/JOP.2011.000535. J Oncol Pract. 2012. PMID: 22942831 Free PMC article.

6

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Ladabaum U, et al. Among authors: wang g. Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002. Ann Intern Med. 2011. PMID: 21768580 Free PMC article.

7

Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.

Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Wang G, et al. Am J Manag Care. 2012 May 1;18(5):e179-85. Am J Manag Care. 2012. PMID: 22694112 Free article.

8

Biomarker use in colorectal cancer therapy.

Kelley RK, Wang G, Venook AP. Kelley RK, et al. Among authors: wang g. J Natl Compr Canc Netw. 2011 Nov;9(11):1293-302. doi: 10.6004/jnccn.2011.0105. J Natl Compr Canc Netw. 2011. PMID: 22056657 Free PMC article. Review.

9

KRAS mutational analysis for colorectal cancer. Application: pharmacogenomic.

Wang G, Kelley RK, Gappnet. Wang G, et al. PLoS Curr. 2010 Sep 2;2:RRN1175. doi: 10.1371/currents.RRN1175. PLoS Curr. 2010. PMID: 20877448 Free PMC article.

10

Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome.

Kuppermann M, Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U. Kuppermann M, et al. Among authors: wang g. Cancer. 2013 Jan 1;119(1):215-25. doi: 10.1002/cncr.27634. Epub 2012 Jul 11. Cancer. 2013. PMID: 22786716 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,927 results

Search Page

Filters